Im-Patient
Maybe. It's worth discussing with your docs at any case. Lately, I've been reading a lot about
irradiating the entire pelvic lymph node area. Like everywhere else, dose escalation seems important for success.
Patel at UT San Antonio has pushed it as high as 54 Gy with IMRT with few SEs. 45 Gy seems to be enough for suspected LNI, especially when there may have been some "overspray" from your SRT treatment. When LNI has been proven by lymphadenectomy or advanced imaging, they may want to bump that up to 50 Gy.
I discussed this recently with my favorite RO. He thinks that there are often micromets in multiple pelvic lymph nodes that are too small to show up in a C11 PET or a USPIO MRI. His feeling is that with the incredible precision of IGRT these days, why not treat the entire pelvic area in high risk cases rather than treat just isolated nodes, since it can probably be done without hurting the bowel tissue? In his new protocol, he will be using SBRT (5 treatments of 5 Gy each, biologically equivalent to 46 Gy with IMRT) to target that area. Sunnybrook is starting a similar clinical trial. The use of SBRT for this is very new and has only been done a handful of times with no long-term data. It offers the opportunity to escalate the biologically effective dose without increasing toxicity (hopefully). Results
may be improved by 2 months of neoadjuvant ADT before treatment.
Another option is to wait for PSA to rise above 2 and look for mets with one of the advanced imaging techniques, and treat those only if there are 5 or fewer. My RO argues that if he can keep the SEs to the bowel low, there may be benefit and little risk to treating all of them.
Something to think about
.
- Allen